Lexaria Bioscience (LEXX) Accounts Payables (2011 - 2026)
Lexaria Bioscience (LEXX) reported Accounts Payables of $350,377 for fiscal Q3 2026 (quarter ended May 31, 2026), down 76.0% from $1.46 million a year earlier but up 91.9% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Accounts Payables (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience posted Accounts Payables of $1.46 million, up 37.2% from FY2024.
- Accounts Payables has increased for five consecutive fiscal years, with a five-year compound annual growth rate of 75.9% (FY2020 to FY2025).
- By fiscal year, Accounts Payables came in at $1.07 million in FY2024 (+344.4%), $239,941 in FY2023 (+58.4%), $151,449 in FY2022 (+42.9%) and $105,946 in FY2021 (+21.9%).
- Five-year quarterly Accounts Payables spans a low of $55,318 in fiscal Q2 2024 and a high of $1.79 million in fiscal Q2 2025.
- Year over year, Accounts Payables gained in four of the last six quarters, with growth averaging 136.3%.
- The high point for year-over-year Accounts Payables in five years was fiscal Q3 2023 (growth of 551.6%); the low point was fiscal Q2 2026 (a decline of 89.8%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $182,611 (Q2 2026), $1.43 million (Q1 2026) and $1.46 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | 350,377.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 350,377.00 |
| Feb 28, 2026 | 182,611.00 |
| Nov 30, 2025 | 1.43 Mn |
| Aug 31, 2025 | 1.46 Mn |
| May 31, 2025 | 1.46 Mn |
| Feb 28, 2025 | 1.79 Mn |
| Nov 30, 2024 | 268,986.00 |
| Aug 31, 2024 | 1.07 Mn |
| May 31, 2024 | 128,788.00 |
| Feb 29, 2024 | 55,318.00 |
| Nov 30, 2023 | 98,969.00 |
| Aug 31, 2023 | 239,941.00 |
| May 31, 2023 | 1.02 Mn |
| Feb 28, 2023 | 189,776.00 |
| Nov 30, 2022 | 241,891.00 |
| Aug 31, 2022 | 151,449.00 |
| May 31, 2022 | 157,095.00 |
| Feb 28, 2022 | 116,592.00 |
| Nov 30, 2021 | 189,542.00 |
| Aug 31, 2021 | 105,946.00 |
API Access
Lexaria Bioscience Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();